Portfolio company
Kedalion Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops electromechanical ocular delivery devices for patients with eye conditions requiring precise topical medication administration.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
INEYE Therapeutics
This company develops ocular drug delivery inserts to treat chronic eye conditions such as dry eye and glaucoma for patients.
Oculis
This biopharmaceutical company develops topical therapies and delivery systems to treat neuro-ophthalmic and ophthalmic diseases for patients with unmet medical needs.
Healome Therapeutics
The company develops eye-drop matrix technology to improve drug delivery and treatment for patients with ocular surface diseases.
Eyexora
This company develops therapeutics and medical devices for ophthalmic diseases to treat patients with vision-threatening conditions.
Rheon Medical SA
This company develops adjustable drainage devices and ocular implants for the surgical treatment of glaucoma in patients.
Perfuse Therapeutics
The company develops sustained-release intravitreal therapies to treat ischemia-driven ocular diseases for patients with conditions like glaucoma and diabetic retinopathy.
Azalea Vision
This company develops smart contact lenses with integrated microelectronics to treat patients suffering from vision disorders and light sensitivity.
Tavo Biotherapeutics
The company develops topical and injectable treatments for patients with glaucoma and retinal diseases.
